European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
Incidence of mastoiditis complications in relation to prior community-based antibiotic treatment.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sofer Nitzan, Hadar Ayalon, Choucroun Gabriel, Tarnovsky Yehuda, Perez Ronen, Attal Pierre, Shaul Chanan
Аннотация
OBJECTIVES: To evaluate the association between prior community-based antibiotic treatment for acute otitis media (AOM) and the incidence and severity of complications in children hospitalized with acute mastoiditis (AM), noting that this design does not address whether prior antibiotic treatment prevents AM development.
METHODS: This retrospective cohort study analyzed medical records of 522 children (age < 15 years) diagnosed with AM at a tertiary medical center between 2015 and 2025. Children were categorized by prior antibiotic exposure: those receiving antibiotics for > 48 h before hospitalization versus those receiving < 48 h or none. The primary outcome was the presence of complicated AM, defined as extracranial (subperiosteal abscess) or intracranial (epidural abscess, sigmoid sinus thrombosis, brain abscess, or meningitis) complications.
RESULTS: Of 522 children, 110 (21%) received prior antibiotics and 412 (79%) did not. While the composite complication rate was higher in the prior treatment group (54.5% vs. 38.6%, unadjusted OR = 1.91, p = 0.003), prior antibiotic treatment was not significantly associated with specific complication types, including subperiosteal abscess (adjusted OR = 0.67, p = 0.37) or intracranial complications (adjusted OR = 1.74, p = 0.13). Inflammatory markers, hospitalization length, imaging use, and surgical intervention rates were comparable between groups. Fusobacterium necrophorum in blood cultures was significantly associated with complications regardless of prior antibiotic exposure.
CONCLUSIONS: Among children hospitalized with AM, prior antibiotic treatment was not associated with increased rates of specific complications. The difference in composite outcomes likely reflects selection bias rather than a true treatment effect. Causal inference is limited by confounding by indication and unmeasured baseline severity differences.
METHODS: This retrospective cohort study analyzed medical records of 522 children (age < 15 years) diagnosed with AM at a tertiary medical center between 2015 and 2025. Children were categorized by prior antibiotic exposure: those receiving antibiotics for > 48 h before hospitalization versus those receiving < 48 h or none. The primary outcome was the presence of complicated AM, defined as extracranial (subperiosteal abscess) or intracranial (epidural abscess, sigmoid sinus thrombosis, brain abscess, or meningitis) complications.
RESULTS: Of 522 children, 110 (21%) received prior antibiotics and 412 (79%) did not. While the composite complication rate was higher in the prior treatment group (54.5% vs. 38.6%, unadjusted OR = 1.91, p = 0.003), prior antibiotic treatment was not significantly associated with specific complication types, including subperiosteal abscess (adjusted OR = 0.67, p = 0.37) or intracranial complications (adjusted OR = 1.74, p = 0.13). Inflammatory markers, hospitalization length, imaging use, and surgical intervention rates were comparable between groups. Fusobacterium necrophorum in blood cultures was significantly associated with complications regardless of prior antibiotic exposure.
CONCLUSIONS: Among children hospitalized with AM, prior antibiotic treatment was not associated with increased rates of specific complications. The difference in composite outcomes likely reflects selection bias rather than a true treatment effect. Causal inference is limited by confounding by indication and unmeasured baseline severity differences.